Department of Chemistry, AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, Delaware 19850, USA.
J Chem Inf Model. 2010 Jul 26;50(7):1296-303. doi: 10.1021/ci100080r.
NovoFLAP is a computer-aided de novo design tool that generates medicinally relevant ideas for ligand-based projects. The approach combines an evolutionary algorithm (EA-Inventor) with a powerful ligand-based scoring function that uses both molecular shape and pharmacophore features in a multiconformational context (FLAP). We demonstrate that NovoFLAP can generate novel ideas that are not only appealing to design scientists but are also validated by comparison to compounds known to demonstrate activity at the desired biological target. NovoFLAP provides a novel computer-aided design technique that can be used to generate ideas that maintain desirable molecular attributes, such as activity at the primary biological target, while offering opportunities to surmount additional design challenges. Application to the design of the first nonbasic 5HT(1B) antagonist is presented.
NovoFLAP 是一款基于配体的从头设计工具,可生成与医学相关的配体项目创意。该方法将进化算法(EA-Inventor)与功能强大的配体打分函数相结合,该函数在多构象环境中使用分子形状和药效团特征(FLAP)。我们证明 NovoFLAP 可以生成不仅吸引设计科学家而且通过与已知在所需生物靶标中具有活性的化合物进行比较来验证的新创意。NovoFLAP 提供了一种新的计算机辅助设计技术,可用于生成保持理想分子属性的创意,例如在主要生物靶标中的活性,同时提供克服其他设计挑战的机会。介绍了用于设计首个非碱性 5HT(1B) 拮抗剂的应用。